Leadership Overview
The Ritedose has 4 executives leading key functions including strategy, information technology, finance, and human resources.
Driven by operational excellence, The Ritedose is dedicated to advancing pharmaceutical manufacturing through innovative packaging solutions and a commitment to quality, impacting healthcare delivery across the United States.
Driven by operational excellence, The Ritedose is dedicated to advancing pharmaceutical manufacturing through innovative packaging solutions and a commitment to quality, impacting healthcare delivery across the United States.
Leadership Roles at The Ritedose
Jody Chastain - President & Chief Executive Officer
Jody Chastain, the President & Chief Executive Officer at The Ritedose, directs the overarching corporate strategy and operational execution for the pharmaceutical manufacturing and packaging facility. Overseeing all business units, Chastain ensures alignment with the company's mission of delivering high-quality pharmaceutical products. This leadership role involves driving innovation in manufacturing processes and expanding market reach within the United States. By optimizing resource allocation and fostering a culture of continuous improvement, Jody Chastain directly impacts the company's growth and its ability to serve healthcare needs. Ultimately, Chastain secures the long-term viability and strategic direction of The Ritedose.
Duane Miskelly - Chief Financial Officer
Duane Miskelly, the Chief Financial Officer at The Ritedose, directs all financial planning, management, and reporting activities for the organization. Overseeing fiscal operations, Miskelly ensures the company's financial health and compliance with all regulatory requirements. This leadership role involves managing budgets, analyzing financial performance, and developing strategies to optimize profitability and resource allocation. By meticulously managing financial resources, Duane Miskelly directly supports the company's manufacturing and packaging operations and its overall business objectives. Ultimately, Miskelly provides critical financial insights to guide strategic decision-making and ensure sustainable growth for The Ritedose.
Shawn Miller - Chief Information Officer
Shawn Miller, the Chief Information Officer at The Ritedose, architects and manages the company's entire technology infrastructure, ensuring robust and secure information systems. Overseeing all digital operations, Miller drives the implementation of advanced IT solutions that support manufacturing efficiency and data integrity. This leadership role involves safeguarding sensitive company and client data, enhancing cybersecurity protocols, and leveraging technology to streamline internal processes. By optimizing the technological framework, Shawn Miller directly supports the company's operational goals and its commitment to reliable pharmaceutical packaging. Ultimately, Miller ensures that The Ritedose maintains a competitive edge through strategic technological advancements.
Janisha Mshrm - Chief Human Resource Officer
Janisha Mshrm, the Chief Human Resource Officer at The Ritedose, leads all human capital management initiatives, fostering a productive and compliant work environment. Overseeing talent acquisition, employee relations, and organizational development, Mshrm ensures the company attracts and retains skilled professionals essential for pharmaceutical manufacturing. This leadership role involves developing and implementing HR policies that align with business objectives and support employee well-being. By cultivating a strong organizational culture and managing workforce dynamics, Janisha Mshrm directly contributes to the operational efficiency and success of The Ritedose. Ultimately, Mshrm champions the company's most valuable asset: its people.
Explore Leadership Teams in Manufacturing
Novartis is a global pharmaceutical manufacturer headquartered in Switzerland, specializing in developing and producing innovative medications and healthcare solutions. The company focuses on research and development of treatments across multiple therapeutic areas to address various medical conditions and improve patient outcomes worldwide. Novartis maintains a significant presence in scientific research, with extensive operations spanning across Europe, North America, Asia, and other global regions.
Company Leadership WV
DC
PD
Cohance is a global Contract Development and Manufacturing Organization (CDMO) specializing in Antibody Drug Conjugates (ADCs), Nucleic Acid Chemistry, and Small Molecules. The company offers a wide range of services including API development, manufacturing, and clinical analytical services, aimed at accelerating the pipeline for pharmaceutical innovators. With a commitment to sustainability and quality, Cohance partners with clients to provide integrated solutions from discovery to commercial scale. Their expertise and innovative approach make them a trusted partner for complex molecule development and manufacturing needs.
Company Leadership
YD
SS
RS
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes for the treatment of hemolytic anemias. The company develops AG-946, a PK activator for treating lower-risk myelodysplastic syndrome and hemolytic anemias; and AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria. Its preclinical product is siRNA for the treatment of polycythemia vera, a rare blood disorder. Agios Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in Cambridge, Massachusetts.
Company Leadership EL
SG
JB
CJ
Formosa Laboratories, Inc. produces APIs and UV-filters in its modern facilities near Taipei. Its GMP compliance has been approved by DOH of Taiwan, US FDA, BGV of Germany, EDQM and PMDA of Japan. Formosas major API products include Vitamin D derivatives (Alfacalcidol, Calcitriol, Calcipotriol, Doxercalciferol, and Paricalcitol), Balsalazide, Benzonatate, Capsaicin, Colesevelam, Gadodiamide, Flupentixol, Melitracen, Meprobamate, Montelukast, Mycophenolate Mofetil, Sevelamer (HCl and Carbonate), and Taltirelin. As a major producer in the world, the company's UV-filter products include avobenzone and Octinoxate. The company also provide custom synthesis service from process development to full commercial production for APIs and other specialty chemicals, with full documentation support.
Company Leadership CY
CC
CY
CC
Frequently Asked Questions Regarding The Ritedose Top Executives and Leadership Team
